NCT07102394 2026-02-17Feasibility and Tolerability of IMLYGIC for the Treatment of Cutaneous Neurofibromas in Adults With NF1Johns Hopkins UniversityPhase 1 Recruiting10 enrolled
NCT06961565 2025-12-04PAS-004 in Adults Who Have Neurofibromatosis Type 1 With Plexiform NeurofibromasPasithea Therapeutics Corp.Phase 1 Recruiting56 enrolled